Education
Work Experience
Certificates
site.doctor_memberships
Avropa Hematologiya Dərnəyi (EHA)
Amerika Hematologiya Cəmiyyəti (ASH)
Hematoloji Onkologiya Cəmiyyəti (SOHO)
Amerika Onkoloji Cəmiyyəti (ASCO)
site.doctor_publications
Does Neutrophil-to-Lymphocyte Ratio Predict Overall Survival in Primary Myelofibrosis?
September 2025. Clinical Lymphoma, Myeloma and Leukemia, 25: S668-S669. E.Guluyev, M.Abbasov, G.Garayeva, A.Kerimov
DOI: 10.1016/S2152-2650(25)02126-3
Genetic profile of primary myelofibrosis patients in Azerbaijan
July 2025, Hematology Transfusion and Cell Therapy, 47:103925. E.Guluyev, M.Abbasov, G.Garayeva, A.Kerimov
DOI: 10.1016/j.htct.2025.103925
Laboratory Characteristics of Prefibrotic and Overt Primary Myelofibrosis in Azerbaijan. Clinical and Laboratory Characteristics of Prefibrotic and Overt Primary Myelofibrosis in Azerbaijan
November 2024, Blood 144(Supplement 1):6666-6666 E.Guluyev, M.Abbasov, A.Kerimov
DOI: 10.1182/blood-2024-200725
Laboratory Characteristics of Patients With Primary Myelofibrosis in Azerbaijan According to Jak2V617F Mutational Status.
September 2024. Clinical Lymphoma, Myeloma and Leukemia, 24:S443. E.Guluyev, M.Abbasov, A.Kerimov
DOI: 10.1016/S2152-2650(24)01454-X
RETROSPECTIVE ANALYSIS OF PRIMARY MYELOFIBROSIS PATIENTS IN AZERBAIJAN.
May 2024, Hematology Transfusion and Cell Therapy, 46:1. E.Guluyev, M.Abbasov, A.Kerimov
DOI: 10.1016/j.htct.2024.04.003
Contacts
